[Prophylaxis of acute respiratory viral infections in organized communities]

Abstract

There are presented the data of placebocontrolled research, which was realized for the purpose of analyze of effectiveness and safety of using of agent "Kagocel" for prophylaxis of acute respiratory virus infections among military servicemen of call-up service. Among persons, got kagocel, was marked a low number of ARVI in comparison with persons, got placebo. The highest prophylactic effect was marked for the first 2 month of getting the agent. A mild disease (ARVI) flow was marked among persons, got placebo. It has approved it self in low frequency of complications. There was shown a grand economic benefit of prophylactic using of kogocel course of treatment.